Evaluation of ROTARIX

dc.contributor.authorLaban NM
dc.contributor.authorBosomprah S
dc.contributor.authorSimuyandi M
dc.contributor.authorChibuye M
dc.contributor.authorChauwa A
dc.contributor.authorChirwa-Chobe M
dc.contributor.authorSukwa N
dc.contributor.authorChipeta C
dc.contributor.authorVelu R
dc.contributor.authorNjekwa K
dc.contributor.authorMubanga C
dc.contributor.authorMwape I
dc.contributor.authorGoodier MR
dc.contributor.authorChilengi R
dc.date.accessioned2025-09-17T10:25:42Z
dc.date.issued2023-Feb-03
dc.description.abstractOral rotavirus vaccines show diminished immunogenicity in low-resource settings where rotavirus burden is highest. This study assessed the safety and immune boosting effect of a third dose of oral ROTARIX
dc.identifier.doi10.3390/vaccines11020346
dc.identifier.urihttps://pubs.cidrz.org/handle/123456789/11885
dc.identifier.uri.pubmedhttps://pubmed.ncbi.nlm.nih.gov/36851224/
dc.relation.affiliationDepartment of Infection Biology, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK.
dc.relation.affiliationCentre for Infectious Disease Research in Zambia (CIDRZ)
dc.relation.affiliationCentre for Infectious Disease Research in Zambia (CIDRZ)
dc.relation.affiliationDepartment of Biostatistics, School of Public Health, University of Ghana, Accra P.O. Box LG13, Ghana.
dc.relation.affiliationCentre for Infectious Disease Research in Zambia (CIDRZ)
dc.relation.affiliationCentre for Infectious Disease Research in Zambia (CIDRZ)
dc.relation.affiliationDepartment of Global Health, Amsterdam Institute for Global Health and Development (AIGHD), Amsterdam University Medical Centers, University of Amsterdam, Paasheuvelweg 25, 1105 BP Amsterdam, The Netherlands.
dc.relation.affiliationCentre for Infectious Disease Research in Zambia (CIDRZ)
dc.relation.affiliationDepartment of Biomedical Sciences, School of Health Sciences, University of Zambia, Lusaka P.O. Box 50110, Zambia.
dc.relation.affiliationCentre for Infectious Disease Research in Zambia (CIDRZ)
dc.relation.affiliationCentre for Infectious Disease Research in Zambia (CIDRZ)
dc.relation.affiliationCentre for Infectious Disease Research in Zambia (CIDRZ)
dc.relation.affiliationCentre for Infectious Disease Research in Zambia (CIDRZ)
dc.relation.affiliationCentre for Infectious Disease Research in Zambia (CIDRZ)
dc.relation.affiliationCentre for Infectious Disease Research in Zambia (CIDRZ)
dc.relation.affiliationDivision of Medical Microbiology, Department of Pathology, Stellenbosch University & National Health Laboratory Service, Tygerberg Hospital Francie van Zijl Drive, Tygerberg, P.O. Box 241, Cape Town 8000, South Africa.
dc.relation.affiliationCentre for Infectious Disease Research in Zambia (CIDRZ)
dc.relation.affiliationDepartment of Infection Biology, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK.
dc.relation.affiliationFlow Cytometry and Immunology Facility, Medical Research Council Unit, The Gambia at London School of Hygiene and Tropical Medicine, Fajara, Banjul P.O. Box 273, The Gambia.
dc.relation.affiliationCentre for Infectious Disease Research in Zambia (CIDRZ)
dc.sourceVaccines
dc.titleEvaluation of ROTARIX

Files

Collections